Cellcolabs Clinical LTD.

StromaForte

clinicaltrials.gov

A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events

Phase 1/2Recruiting2023100 people18 Oct 2023clinicaltrials.gov

A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration

Phase 1/2Recruiting202330 people10 Oct 2023clinicaltrials.gov

A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty

Phase 1/2Not yet recruiting202512 people6 Oct 2023clinicaltrials.gov